@inproceedings{b0d5a12194ec4201a6bc2353e4d7c740,
title = "Predicting success in massive open online courses (Moocs) using cohesion network analysis",
abstract = "This study uses Cohesion Network Analysis (CNA) indices to identify student patterns related to course completion in a massive open online course (MOOC). This analysis examines a subsample of 320 students who completed at least one graded assignment and produced at least 50 words in discussion forums in a MOOC on educational data mining. The findings indicate that CNA indices predict with substantial accuracy (76%) whether students complete the MOOC, helping us to better understand student retention in this MOOC and to develop more actionable automated signals of student success.",
author = "Crossley, {Scott A.} and Mihai Dascalu and McNamara, {Danielle S.} and Ryan Baker and Stefan Trausan-Matu",
note = "Funding Information: Research funding: The current study was funded with general salary support by the West Virginia University National Center of Excellence in Women{\textquoteright}s Health in conjunction with the West Virginia University School of Medicine, Department of Obstetrics and Gynecology. Funding Information: Competing interests: The corresponding and first author, through collaboration with the West Virginia University Heart and Vascular Institute, the West Virginia University Clinical and Translational Science Institute, the National Institute of Health, and the National Institute of General Medical Sciences, were recently awarded a grant investigating myocardial blood flow in menopausal women through magnetic resonance imaging, with and without hormone replacement therapy. Dr Renzelli-Cain is currently involved in a writers{\textquoteright} agreement and is funded by AbbVie Pharmaceuticals. AbbVie Pharmaceutical manufactures the drug Vicodin, which is used to manage pain. The author{\textquoteright}s writer{\textquoteright}s agreement and currently-funded grant with AbbVie Pharmaceuticals pertains to a study and publication with Orilissa (elagolix), a medication used to treat endometriosis and associated pelvic pain and dyspareunia. Dr Renzelli-Cain does not speak on long-acting reversible contraceptives or any other form of contraception. Dr Renzelli-Cain is also an unpaid speaker for Hologic-Cynosure. Her lectures describe the novel use of MONA LISA laser treatment for genitourinary syndrome of menopause and associated dyspareunia. These associations did not influence the methodology, analysis, or conclusions of this article. Publisher Copyright: {\textcopyright} ISLS.; 12th International Conference on Computer Supported Collaborative Learning - Making a Difference: Prioritizing Equity and Access in CSCL, CSCL 2017 ; Conference date: 18-06-2017 Through 22-06-2017",
year = "2017",
language = "English (US)",
series = "Computer-Supported Collaborative Learning Conference, CSCL",
publisher = "International Society of the Learning Sciences (ISLS)",
pages = "103--110",
editor = "Smith, {Brian K.} and Marcela Borge and Emma Mercier and Lim, {Kyu Yon}",
booktitle = "Making a Difference",
}